These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 20570743)

  • 141. Inclusion of Safety Pharmacology Endpoints in Repeat-Dose Toxicity Studies.
    Redfern WS
    Handb Exp Pharmacol; 2015; 229():353-81. PubMed ID: 26091647
    [TBL] [Abstract][Full Text] [Related]  

  • 142. Haemodynamic Assessment in Safety Pharmacology.
    Authier S; Pugsley MK; Curtis MJ
    Handb Exp Pharmacol; 2015; 229():221-41. PubMed ID: 26091642
    [TBL] [Abstract][Full Text] [Related]  

  • 143. Impact of movement on cardiorespiratory coordination in conscious rats.
    Kabir MM; Nalivaiko E; Abbott D; Baumert M
    Annu Int Conf IEEE Eng Med Biol Soc; 2010; 2010():1938-41. PubMed ID: 21097002
    [TBL] [Abstract][Full Text] [Related]  

  • 144. Some aspects of toxicological activity of kardosten after chronic 6-month administration to rats.
    Petrov VI; Bugaeva LI; Lebedeva SA; Lavrova EV; Dugina YL; Kheifets IA; Zabolotneva YA; Sergeeva SA; Epstein OI
    Bull Exp Biol Med; 2010 Dec; 150(2):215-8. PubMed ID: 21240376
    [TBL] [Abstract][Full Text] [Related]  

  • 145. Core battery safety pharmacology testing - An assessment of its utility in early drug development.
    Baldrick P
    J Pharmacol Toxicol Methods; 2021; 109():107055. PubMed ID: 33813006
    [TBL] [Abstract][Full Text] [Related]  

  • 146. Repeated "Day 1" FOB testing in ICH S7A safety assessment protocols: The influence of within- and between-session learning.
    Gauvin DV; Zimmermann ZJ; Dalton JA; Baird TJ
    J Pharmacol Toxicol Methods; 2017; 85():61-72. PubMed ID: 28216425
    [TBL] [Abstract][Full Text] [Related]  

  • 147. Proceedings: An intact animal preparation for cardiovascular pharmacological studies.
    Cross MR; Weller C; Raftery EB
    Clin Sci Mol Med; 1974 Aug; 47(2):7P. PubMed ID: 4415238
    [No Abstract]   [Full Text] [Related]  

  • 148. Technological Advances in Cardiovascular Safety Assessment Decrease Preclinical Animal Use and Improve Clinical Relevance.
    Berridge BR; Schultze AE; Heyen JR; Searfoss GH; Sarazan RD
    ILAR J; 2016 Dec; 57(2):120-132. PubMed ID: 28053066
    [TBL] [Abstract][Full Text] [Related]  

  • 149. Testing the Translational Power of the Zebrafish: An Interspecies Analysis of Responses to Cardiovascular Drugs.
    Margiotta-Casaluci L; Owen SF; Rand-Weaver M; Winter MJ
    Front Pharmacol; 2019; 10():893. PubMed ID: 31474857
    [TBL] [Abstract][Full Text] [Related]  

  • 150. [Cardiovascular system and phenylbutazone therapy; experimental and clinical study].
    CURZIO A; FRANCO G
    Reumatismo; 1955; 7(5):286-93. PubMed ID: 13280929
    [No Abstract]   [Full Text] [Related]  

  • 151. [Cardiovascular depressor effect of intramuscularly administered nivaquine].
    PASTOR BOTIJA F
    Med Colon; 1956 Apr; 27(4):353-5. PubMed ID: 13333496
    [No Abstract]   [Full Text] [Related]  

  • 152. Monitoring haemodynamic changes in rodent models to better inform safety pharmacology: Novel insights from
    Van Daele M; Cooper SL; Pannucci P; Wragg ES; March J; de Jong I; Woolard J
    JRSM Cardiovasc Dis; 2022; 11():20480040221092893. PubMed ID: 35646334
    [TBL] [Abstract][Full Text] [Related]  

  • 153. Spontaneously occurring cardiovascular lesions in commonly used laboratory animals.
    Herman E; Eldridge S
    Cardiooncology; 2019; 5():6. PubMed ID: 32154013
    [TBL] [Abstract][Full Text] [Related]  

  • 154. Practical Considerations in Clinical Pathology Data Interpretation and Description.
    Hall RL
    Toxicol Pathol; 2017 Feb; 45(2):362-365. PubMed ID: 27729587
    [TBL] [Abstract][Full Text] [Related]  

  • 155. Corrigendum to "The in vivo QTc core assay: An evaluation of QTc variability, detection sensitivity and implications for the improvement of conscious dog and non-human primate telemetry studies" [Journal of Pharmacological and Toxicological Methods 109 (2021) 107067].
    Baublits J; Vargas HM; Engwall MJ
    J Pharmacol Toxicol Methods; 2021; 112():107104. PubMed ID: 34334315
    [No Abstract]   [Full Text] [Related]  

  • 156. Cardiovascular effects of acutely produced anemia in the normal dog.
    Sunahara FA; Beck L
    Am J Physiol; 1954 Jan; 176(1):139-42. PubMed ID: 13124510
    [No Abstract]   [Full Text] [Related]  

  • 157. A super-powered S-layer.
    Deane C
    Nat Chem Biol; 2019 Mar; 15(3):207. PubMed ID: 30770912
    [No Abstract]   [Full Text] [Related]  

  • 158. Preclinical to Clinical Translation of Hemodynamic Effects in Cardiovascular Safety Pharmacology Studies.
    Bhatt S; Northcott C; Wisialowski T; Li D; Steidl-Nichols J
    Toxicol Sci; 2019 May; 169(1):272-279. PubMed ID: 30726989
    [TBL] [Abstract][Full Text] [Related]  

  • 159. Translational science approach for assessment of cardiovascular effects and proarrhythmogenic potential of the beta-3 adrenergic agonist mirabegron.
    Korstanje C; Suzuki M; Yuno K; Sato S; Ukai M; Schneidkraut MJ; Yan GX
    J Pharmacol Toxicol Methods; 2017 Sep; 87():74-81. PubMed ID: 28434969
    [TBL] [Abstract][Full Text] [Related]  

  • 160. Cardiovascular Adverse Effects of Phenylephrine Eyedrops: A Systematic Review and Meta-analysis.
    Stavert B; McGuinness MB; Harper CA; Guymer RH; Finger RP
    JAMA Ophthalmol; 2015 Jun; 133(6):647-52. PubMed ID: 25789577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.